KD Logo

Abeona Therapeutics Inc [NASDAQ: ABEO] Sees Increase in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abeona Therapeutics Inc shares valued at $116,764 were sold by Alvino Mark on Jun 18 ’24. At $4.51 per share, Alvino Mark sold 25,890 shares. The insider’s holdings dropped to 36,926 shares worth approximately $0.16 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Silverstein Christine Berni sold 25,821 shares, netting a total of over 116,453 in proceeds. Following the sale of shares at $4.51 each, the insider now holds 62,063 shares.

Before that, Alland Leila had added 11,000 shares to its account. In a trade valued at $51,799, the Director bought Abeona Therapeutics Inc shares for $4.71 each. Upon closing the transaction, the insider’s holdings increased to 11,000 shares, worth approximately $0.36 million.

As published in their initiating research note from H.C. Wainwright on July 03, 2024, Abeona Therapeutics Inc [ABEO] has been a Buy and the price target has been revised to $15. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of November 11, 2020, Cantor Fitzgerald has increased its “Neutral” rating to a “an Overweight” for ABEO. Earlier on September 18, 2020, B. Riley FBR initiated its rating. Their recommendation was “a Buy” for ABEO stock.

Analyzing ABEO Stock Performance

During the last five days, there has been a surge of approximately 6.36%. Over the course of the year, Abeona Therapeutics Inc shares have dropped approximately -13.17%. Shares of the company reached a 52-week high of $9.01 on 03/06/24 and a 52-week low of $3.05 on 04/25/24. A 50-day SMA is recorded $4.24, while a 200-day SMA reached $5.18. Nevertheless, trading volume fell to 0.2 million shares from 0.12 million shares the previous day.

Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)

According to the 24-hour chart, there is a support level at 4.21, which, if violated, would cause prices to drop to 4.07. In the upper region, resistance lies at 4.44. The next price resistance is at 4.53. RSI (Relative Strength Index) is 48.41 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.14, which suggests the price will decrease in the coming days. Percent R is at 60.26%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular